Mannitol En Flacon Verre B. Braun

Mannitol, the active ingredient in Mannitol En Flacon Verre B. Braun, is an osmotic diuretic presented as a solution for injection for intravenous use. It reduces intracranial pressure and supports renal function in acute clinical settings.\n\nGNH India supplies Mannitol En Flacon Verre B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol is employed in several acute care pathways where fluid balance and pressure reduction are critical.\n\n- Reduction of intracranial pressure: lowers pressure in traumatic brain injury, stroke or postoperative cerebral edema.\n- Acute renal failure with oliguria: promotes diuresis to manage fluid overload and improve renal perfusion.\n- Promotion of diuresis in various clinical settings: facilitates urine output during surgery, cardiopulmonary bypass or severe electrolyte disturbances.

Mannitol may cause a range of adverse reactions that vary in frequency and severity.\n\nCommon Side Effects:\n- Headache: mild to moderate discomfort often related to rapid osmotic shifts.\n- Nausea or vomiting: gastrointestinal upset following infusion.\n- Thirst or dry mouth: due to increased plasma osmolality.\n- Transient hypotension: drop in blood pressure during rapid administration.\n- Electrolyte imbalance: especially hyponatremia or hypokalemia.\n\nSerious or Rare Side Effects:\n- Severe allergic reaction: anaphylaxis or urticaria requiring immediate medical attention.\n- Pulmonary edema: fluid accumulation in lungs from excessive volume expansion.\n- Worsening renal failure: especially in patients with pre‑existing kidney impairment.\n- Cardiac arrhythmia: secondary to electrolyte disturbances.\n- Hemolysis: rare but possible with rapid high‑dose infusion.

Mannitol should be used with careful monitoring and adherence to safety guidelines.\n\n- Renal function: assess baseline creatinine and monitor urine output closely.\n- Electrolytes: check serum sodium, potassium and osmolality before and during therapy.\n- Cardiovascular status: observe blood pressure and heart rate for hypotensive episodes.\n- Pregnancy: consider only when benefits outweigh potential risks to the fetus.\n- Drug compatibility: verify compatibility with IV fluids and other administered agents.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with several drug classes, requiring vigilance.\n\nMajor Interactions (Avoid):\n- Loop diuretics: may cause excessive fluid loss and electrolyte depletion.\n- ACE inhibitors or ARBs: increased risk of renal impairment when combined.\n- Lithium: heightened lithium toxicity due to altered renal clearance.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents: additive hypotensive effect, monitor blood pressure.\n- Nephrotoxic antibiotics (e.g., aminoglycosides): monitor renal function closely.